Your browser doesn't support javascript.
loading
Prognostic Factors After Pancreatectomy for Pancreatic Cancer Initially Metastatic to the Liver.
Frigerio, Isabella; Malleo, Giuseppe; de Pastena, Matteo; Deiro, Giacomo; Surci, Niccolò; Scopelliti, Filippo; Esposito, Alessandro; Regi, Paolo; Giardino, Alessandro; Allegrini, Valentina; Bassi, Claudio; Girelli, Roberto; Salvia, Roberto; Butturini, Giovanni.
  • Frigerio I; Pancreatic Surgical Unit, Department of General and Vascular Surgery, Pederzoli Hospital, Peschiera del Garda, Verona, Italy. isifrigerio@yahoo.com.
  • Malleo G; Unit of Pancreatic Surgery, University of Verona Hospital Trust, Verona, Italy.
  • de Pastena M; Unit of Pancreatic Surgery, University of Verona Hospital Trust, Verona, Italy.
  • Deiro G; Unit of Pancreatic Surgery, University of Verona Hospital Trust, Verona, Italy.
  • Surci N; Pancreatic Surgical Unit, Department of General and Vascular Surgery, Pederzoli Hospital, Peschiera del Garda, Verona, Italy.
  • Scopelliti F; Department of Surgery, Medical University of Vienna, General Hospital, Vienna, Austria.
  • Esposito A; Pancreatic Surgical Unit, Department of General and Vascular Surgery, Pederzoli Hospital, Peschiera del Garda, Verona, Italy.
  • Regi P; Unit of Pancreatic Surgery, University of Verona Hospital Trust, Verona, Italy.
  • Giardino A; Pancreatic Surgical Unit, Department of General and Vascular Surgery, Pederzoli Hospital, Peschiera del Garda, Verona, Italy.
  • Allegrini V; Pancreatic Surgical Unit, Department of General and Vascular Surgery, Pederzoli Hospital, Peschiera del Garda, Verona, Italy.
  • Bassi C; Pancreatic Surgical Unit, Department of General and Vascular Surgery, Pederzoli Hospital, Peschiera del Garda, Verona, Italy.
  • Salvia R; Pancreatic Surgical Unit, Department of General and Vascular Surgery, Pederzoli Hospital, Peschiera del Garda, Verona, Italy.
  • Butturini G; Unit of Pancreatic Surgery, University of Verona Hospital Trust, Verona, Italy.
Ann Surg Oncol ; 29(13): 8503-8510, 2022 Dec.
Article en En | MEDLINE | ID: mdl-35976466
ABSTRACT

BACKGROUND:

Resection of initially oligometastatic pancreatic ductal adenocarcinoma (PDAC) following response to first-line chemotherapy is controversial. We herein updated a previous case series to investigate the oncologic outcomes and preoperative factors that could drive the decision-making process.

METHODS:

This retrospective analysis was limited to patients with liver-only synchronous metastases who experienced complete regression of the metastatic component and underwent pancreatectomy between October 2008 and July 2020 at two high-volume institutions. Clinical-pathologic variables were captured, and inflammation-based prognostic scores were calculated. Recurrence and survival analyses were performed using standard statistical methods.

RESULTS:

Overall, 52 patients were included. FOLFIRINOX was the most employed chemotherapy regimen (63.5%). Post-treatment tumor size, serum carbohydrate antigen (CA) 19-9 and carcinoembryonic antigen (CEA) were significantly decreased relative to baseline evaluation. The median time from diagnosis to pancreatectomy was 10.2 months, while the median time from chemotherapy completion to pancreatectomy was 2 months. Major postoperative complications occurred in 26.9% of patients, while postoperative mortality was nil. The median disease-free survival (DFS) and overall survival (OS) from pancreatectomy were 16.5 and 23.0 months, respectively, and the median OS from diagnosis was 37.2 months. At multivariable analysis, vascular resection, operative time, prognostic nutrition index (PNI) and neutrophil-to-lymphocyte ratio (NLR) were associated with OS. Operative time, platelet × neutrophil/lymphocyte count (SII), and PNI were associated with DFS.

CONCLUSIONS:

We confirm promising outcomes of selected patients who underwent pancreatectomy following downstaging of liver metastases. The absence of vascular involvement of the primary tumor, good nutritional status, and low inflammatory index scores could be useful to select candidates for resection.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Carcinoma Ductal Pancreático / Neoplasias Hepáticas Tipo de estudio: Observational_studies / Prognostic_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Carcinoma Ductal Pancreático / Neoplasias Hepáticas Tipo de estudio: Observational_studies / Prognostic_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article